Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 17;12(1):e003609.
doi: 10.1136/bmjdrc-2023-003609.

Association of urinary albumin-to-creatinine ratio with cardiometabolic risk markers and pre-diabetes in adults with normoglycemia, normoalbuminuria, and normotension with parental type 2 diabetes

Affiliations

Association of urinary albumin-to-creatinine ratio with cardiometabolic risk markers and pre-diabetes in adults with normoglycemia, normoalbuminuria, and normotension with parental type 2 diabetes

Matthew Everett et al. BMJ Open Diabetes Res Care. .

Abstract

Introduction: This is a post hoc analysis of urinary albumin-to-creatinine ratio (uACR) within the normoalbuminuric range in relation to cardiometabolic risk factors among initially normoglycemic, normotensive participants in the Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC) Study.

Research design and methods: 308 healthy African American (AA) and European American (EA) participants in the POP-ABC Study underwent baseline assessments, including oral glucose tolerance test, anthropometry, urinary albumin-to-creatinine ratio (uACR), lipids, adipocytokines, insulin sensitivity and secretion. Participants were followed quarterly for 5.5 years (mean 2.62 years) for the primary outcome of incident pre-diabetes.

Results: The cohort's mean fasting glucose was 92.1±6.90 mg/dL, 2-hour plasma glucose was 123±25.0 mg/dL, systolic blood pressure was 123±15.9 mm Hg, and diastolic blood pressure was 74±8.80 mm Hg. Baseline uACR levels (range 1-29 mg/g) were similar in AA versus EA participants (6.40 mg/g±4.80 vs 6.80±5.40 mg/g, p=0.52), higher in women than men (7.30 mg/g±5.30 vs 4.60±3.90 mg/g, p<0.0001), and showed significant associations with cardiometabolic risk factors, including age, insulin sensitivity, high-density lipoprotein cholesterol, and adiponectin levels (p=0.03-0.004). During 5.5 years of follow-up, 104 participants developed pre-diabetes and 204 maintained normoglycemia. Baseline uACR quartiles were associated with incident pre-diabetes (r=0.19, p=0.0011).

Conclusions: Baseline uACR levels were associated with cardiometabolic risk markers and incident pre-diabetes risk among adults with normoglycemia, normoalbuminuria and normotension with parental diabetes.

Keywords: Albuminuria; Ethnic Groups; Impaired Fasting Glucose; Impaired Glucose Tolerance.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Percentile distribution of urinary albumin-to-creatinine ratio (uACR) in (A) black (purple symbol) and white (green symbol) participants and (B) female (blue symbol) and male (red symbol) participants in the POP-ABC Study. uACR distribution was similar in black versus white participants but significantly higher in women than men (p<0.0001). POP-ABC, Pathobiology of Prediabetes in a Biracial Cohort.
Figure 2
Figure 2
Association of urinary albumin-to-creatinine ratio (uACR) with (A) serum high-density lipoprotein (HDL) cholesterol levels, (B) serum adiponectin levels and (C) insulin sensitivity in African American (red symbols) and European American (blue symbols) study participants; (D) pre-diabetes incidence across quartiles of baseline uACR among female study participants (uACR quartiles (mg/g): Q1: 0–<4; Q2: 4–<6; Q3: 6–<9; Q4: 9–<30).

Similar articles

References

    1. Gerstein HC, Mann JF, Yi Q, et al. . Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001;286:421–6. 10.1001/jama.286.4.421 - DOI - PubMed
    1. Brantsma AH, Bakker SJL, Hillege HL, et al. . Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 2005;28:2525–30. 10.2337/diacare.28.10.2525 - DOI - PubMed
    1. Arnlöv J, Evans JC, Meigs JB, et al. . Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham heart study. Circulation 2005;112:969–75. 10.1161/CIRCULATIONAHA.105.538132 - DOI - PubMed
    1. de Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: public health perspectives. J Am Soc Nephrol 2006;17:2120–6. 10.1681/ASN.2006010097 - DOI - PubMed
    1. Klausen K, Borch-Johnsen K, Feldt-Rasmussen B, et al. . Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes. Circulation 2004;110:32–5. 10.1161/01.CIR.0000133312.96477.48 - DOI - PubMed